Anavex Life Sciences Q2 EPS $(0.06) Beats $(0.08) Estimate
Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 53.85 percent increase over losses of $(0.13) per share
Anavex lost money this quarter, but lost *less* money than experts thought it would—kind of like spending $6 instead of $8 when you only have $10. When a company that's still losing money does better than expected, people often feel a little more hopeful about its future.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.